Is LFCR or LGND more undervalued in 2026?

CirclFi compares Lifecore Biomedical, Inc. (LFCR) and Ligand Pharmaceuticals Incorpor (LGND) using 13 institutional-grade valuation models. LFCR has a Quality of Company score of 4.9/10 while LGND scores 7.8/10.

Which is a better buy — LFCR or LGND?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LFCR and LGND valuations compare?

LFCR at $5.02 and LGND at $231.96 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LFCR vs LGND Valuation Comparison 2026 — Intrinsic Value Analysis

LFCR

Pharmaceutical Preparations

Lifecore Biomedical, Inc.

Quality

4.9

out of 10

Value Trap

SAFE

Price

$5.02

Last close

Models

7/13

Active

LGND

Pharmaceutical Preparations

Ligand Pharmaceuticals Incorpor

Quality

7.8

out of 10

Value Trap

LOW

Price

$231.96

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	LFCR Fair Value	LFCR Upside	LGND Fair Value	LGND Upside
Bayesian DCF	Intrinsic	—	—	$66.47	-71.3%
Earnings Power Value	Intrinsic	—	—	$57.08	-75.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$0.61	-86.0%	$198.61	-14.4%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$5.31	+5.7%	$232.05	+0.0%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LFCR vs LGND — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LFCR vs LGND — Which Stock Is More Undervalued?

LGND scores higher with a 7.8/10 quality rating vs LFCR's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lifecore Biomedical, Inc. (LFCR) and Ligand Pharmaceuticals Incorpor (LGND) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LFCR currently trades at $5.02 with a QOC of 4.9/10, while LGND trades at $231.96 with a QOC of 7.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).